An example of this phenomenon includes chronic lymphocytic leukemia (CLL) cells that are especially resistant to SMAC mimetics targeting cIAP1/cIAP2 activity [139]. The gene discussed is BIRC3; the disease is B-cell chronic lymphocytic leukemia.